The Use of Self Infused IVIG Home Therapy in Trtm of Acquired Chronic Demyel Neuropathies
JNNP 63:106-109, Sewell,W.A.C.,et al, 1997
Cerebral Tuberculosis in Pts with AIDS, Report of 6 Cases & Review
Medicine 76:423-431, Lesprit,P.,et al, 1997
Heroin Inhalation and Progressive Spongiform Leukoencephalopathy
Neurol 48:589-590, Kriegstein,A.R.,et al, 1997
Crack Cocaine Use and Stroke in Young Patients
Neurol 48:341-345, Qureshi,A.I.,et al, 1997
Parkinsonism Associated with Long-Term Cocaine Abuse
Arch Int Med 157:241, Domingo,P.&Martinez,E., 1997
Randomised Placebo-Controlled Trial of Monthly IVIg Therapy in Relapsing-Remitting MS
Lancet 349:589-593, 5861997., Fazekas,F.,et al, 1997
Coma Induced by Abuse of Gamma-Hydroxybutyrate (GBH or Liquid Ecstasy) :A Case Report
BMJ 314:35-36, Thomas,G.,et al, 1997
Neurologic Complic of Treat of Childhood Acute Immune Thrombocytopenic Purpura with IVIG
J Pediatr 130:281-283, Kattamis,A.C.,et al, 1997
Acute Bacterial Meningitis in Adults, A 20-Yr Overview
Arch Int Med 157:425-430, Sigurdardottir,B.,et al, 1997
CIDP:Clinical Features & Responses to Trtm in 67 Consecutive Pts with/without a Monoclonal Gammopathy
Neurol 48:321-328, Gorson,K.G.,et al, 1997
Gluteal Compartment Syndrome Due to Rhabdomyolysis After Heroin Abuse
Neurol 48:275-276, Klockgether,T.,et al, 1997
Tuberculous Brain Abscess in a Patient with HIV Infection:Case Report and Review
Am J Med 102:297-301, Farrar,D.J.,et al, 1997
Local Thrombolytic Therapy in Deep Cerebral Venous Thrombosis
Neurol 48:1613-1619, Smith,A.G.,et al, 1997
Endovascular Thrombolysis in Deep Cerebral Venous Thrombosis
AJNR 18:502-506, Spearman,M.P.,et al, 1997
Direct Endovascular Thrombolytic Therapy for Dural Sinus Thrombosis:Infusion of Alteplase
AJNR 18:639-645, Kim,S.Y.&Suh,J.H., 1997
A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997
Stroke Following Central Venous Cannulation
Lancet 349:921, Mainland,P-A.,et al, 1997
Ischemic Cerebral Infarction After rt-PA and Heparin Therapy for Acute Myocardial Infarction
Stroke 28:1107-1114, Sloan,M.A.,et al, 1997
Brain SPECT with HMPAO & Safety of Thrombolytic Therapy in Acute Ischemic Stroke
Stroke 28:1830-1834, Alexandrov,A.V.,et al, 1997
Hemorrhagic Transformation in Acute Ischemic Stroke
Stroke 28:957-960, Larrue,V.,et al, 1997
Intravenous Thrombolysis for Acute Stroke
Neurol 49:14-29, Lyden,P.D.,et al, 1997
Systematic Review of Evidence on Thrombolytic Therapy for Acute Ischaemic Stroke
Lancet 350:607-614, Wardlaw,J.M.,et al, 1997
A Systems Approach to Immediate Evaluation and Management of Hyperacute Stroke
NINDS Stroke Study Group, Stroke 28:1530-15401997., , 1997
Butorphanol (Stadol) :A Study in Problems of Current Drug Information and Control
Neurol 48:1156-1160, Fisher,M.A.&Glass,S., 1997
Cerebral Infarction in Patients with AIDS
AJNR 18:1581-1585, Gillams,A.R.,et al, 1997
Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997
Human T-Cell Lymphotrophic Virus Type II-Associated Myelopathy:Clinical and Immunologic Profiles
Ann Neurol 40:714-723, Lenky,T.J.,et al, 1996
Idiopathic Dysautonomia Treated with Intravenous Gammaglobulin
Lancet 347:28-29, Heafield,M.T.E.,et al, 1996
The Residual Cognitive Effects of Heavy Marijiana Use in College Students
Pope. H. G. & Yurgelun-Todd, D. , JAMA 275:521-527, , 1996
Reversible Encephalopathy with Cerebral Vasospasm in a Guillain-Barre Syndrome Patient Treated with Intravenous Immunoglobulin
Neurol 46:250-251, Voltz,R.,et al, 1996
Liver Function Disturbances in Guillain-Barre Syndrome:A Prospective Longitudinal Study in 100 Patients
Neurol 46:96-100, Oomes,P.G.,et al, 1996
Pilot Trial of Immunoglobulin Versus Plasma Exchange in Patients with Guillain-Barre Syndrome
Neurol 46:100-103, Bril,V.,et al, 1996
Exacerbation of Myasthenia Gravis Associated with Cocaine Use
Neurol 46:271-272, Daras,M.,et al, 1996
Prognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score Before Ultraearly Thrombolytic Therapy
AJNR 17:79-85, Tomsick,T.,et al, 1996
AIDS in the Elderly:New York City Vital Statistics
J Emerg Med 14:19-23, Gaeta,T.J.,et al, 1996
A Controlled Study of Intravenous Immunoglobulin in Demyelinating Neuropathy with IgM Gammopathy
Ann Neurol 40:792-795, Dalakas,M.C.,et al, 1996
Tissue-Type Plasminogen Activator Should Not be Used in Acute Ischemic Stroke
Arch Neurol 53:1306-1308, Riggs,J.E., 1996
Thrombolysis for Stroke
Arch Neurol 53:1305-1306, 13081996., Brott,T., 1996
TPA Within 3 Hours of Acute Ischaemic Stroke
Lancet 348:1600-1601, Dorman,P.&Sandercock,P., 1996
Intraarterial Thrombolysis in Vertebrobasilar Occlusion
AJNR 17:255-262, Becker,K.J.,et al, 1996
Hemorrhagic Transfor of Brain Infarct:Predictability in First 5 hrs. From Stroke Onset & Influ on Clin Outcome
Neurol 46:341-345, Toni,D.,et al, 1996
Complications of Intravenous Gammaglobulin in Neuromuscular and other Disease
Muscle & Nerve 19:388-391996., Bertorini,T.E.,et al, 1996
Treatment of Opsoclonus-Myoclonus with High-Dose Intravenous Immunoglobulin
Neurol 46:583-584, Pless,M.,et al, 1996
Treatment of Vogt-Koyanagi-Herada Syndrome with Intravenous Immunoglobulin
Neurol 46:584-585, Helveston,W.R.&Gilmore,R., 1996
Multifocal Motor Neuropathy with Conduction Block and Campylobacter Jejuni
Neurol 46:562-563, White,J.R.,et al, 1996
Intra-Arterial Thrombolysis in Acute Ischaemic Stroke:Experience with a Superselective Catheter Embedded in the Clot
JNNP 60:667-670, Castro,L.,et al, 1996
Thrombolytic Therapy of Acute Basilar Artery Occlusion-Variables Affecting Recanalization and Outcome
Stroke 27:875-881, Brandt,T.,et al, 1996
Open Trial of I. V. Tissue Plasminogen Activator in Acute Carotid Territory Stroke-Correl of Outcome with Clin & Radiol Data
Stroke 27:882-890, Trouillas,P.,et al, 1996
Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke
The MAST-E Study Group, NEJM 335:145-1501996., , 1996
Thrombolytic Therapy for Acute Ischemic Stroke-Summary Statement
Report of the Quality Standards Subcommittee of the AAN, Neurol 47:835-8391996., , 1996